Study explores characteristic developmental patterns in autismJuly 1st 2012
To describe the typical longitudinal developmental trajectories of social and communication functioning and repetitive behavior in children with autism, investigators analyzed data from birth records and a database of the California Department of Developmental Services that recorded symptom severity and functioning in nearly 7,000 children aged from 2 to 14 years with autism.
Medical home model is underused for children with autism spectrum disorderJuly 1st 2012
Children with autism spectrum disorder need greater access to the coordinated care available through a medical home, according to a systematic review of 13 studies that examined health care use, health care expenditures, and access to services by children with ASD.
DSM-V criteria for diagnosis of autism criticism rebuttedJune 1st 2012
A proposed revision to the DSM-V criteria for a diagnosis of autism had critics charging that many patients with autism spectrum disorders would no longer quality for their diagnoses and would lose access to government services.
Simple test may signal autism riskMay 31st 2012
A simple pull-to-sit test of posture control at 6 months may indicate inappropriate neurologic development and warn of autism spectrum disorder in children at high genetic risk. What are the implications for screening and treatment?
SRIs may have effect on repetitive behaviors in ASDApril 26th 2012
Serotonin receptor inhibitors may have a small but significant effect in the treatment of restricted and repetitive behaviors in autism spectrum disorders, according to an analysis of randomized trials. But is there a publication bias?
CDC estimates 1 in 88 children has an autism spectrum disorderApril 5th 2012
Autism spectrum disorders (ASDs) now affect 1 in 88 children in the United States and are almost 5 times more common among boys than girls, according to estimates based on a new study from the Centers for Disease Control and Prevention (CDC) Autism and Developmental Disabilities Monitoring (ADDM) Network. Why are the numbers growing?
Youngest children in class more likely to be diagnosed with ADHDMarch 22nd 2012
A study of Canadian children found that the youngest children in the class are significantly more likely to be diagnosed with attention-deficit/hyperactivity disorder (ADHD) and prescribed medication than their peers in the same grade. Find out why overdiagnosis and overprescribing are a concern.
Research reveals brain differences at 6 months in infants who develop autismFebruary 23rd 2012
An ongoing study that could lead to an imaging biomarker for autism as early as 6 months, before the onset of observable behavioral symptoms, may also eventually provide practitioners an avenue for earlier intervention in autism spectrum disorders
Co-occurring conditions sometimes leads to a change in ASD diagnosisJanuary 26th 2012
Certain characteristics of autism spectrum disorder (ASD) may change as a child ages. An analysis of a national survey of children’s health found that children with a current diagnosis of ASD were more likely to have a co-occurring neurodevelopmental or psychiatric condition, such as learning disability or depression, than those with a past (but not current) diagnosis of ASD. This is important information to have when arriving at an ASD diagnosis.
Most pediatricians skip ECG before starting ADHD stimulantsJanuary 26th 2012
Results of a survey of AAP members show that most US pediatricians bypass an ECG before starting children on stimulant medication for ADHD, opting for a routine cardiac history and physical examination instead. Find out how perceived barriers to cardiac screening influence clinical practice.
ADHD screening: Begin earlier, continue longerOctober 20th 2011
Evaluations for attention-deficit/hyperactivity disorder (ADHD) should begin in children at 4 years and continue until 18 years, which significantly expands the age range for recommended screening. Released at the American Academy of Pediatrics National Conference in Boston, Massachusetts, the clinical practice guidelines recommend behavioral interventions as the first-line treatment in preschool children. The guidelines also have some new suggestions related to methylphenidate treatment for children younger than 6 years.
ADHD increase higher in economically disadvantaged childrenAugust 25th 2011
Here?s some new information that can help when you?re determining whom to screen for attention-deficit/hyperactivity disorder: ADHD prevalence has increased to 10% for children with family income less than 100% of the poverty level and to 11% for those with family income between 100% and 199% of the poverty level compared with a 7% to 9% overall increase, according to a National Center for Health Statistics report. Read more to find out what other indicators were linked with above-average increases in the disorder?s prevalence.
Younger siblings of autism patients need extra surveillanceAugust 18th 2011
Family history is more important than previously thought in autism spectrum disorder, and pediatricians should consider early intervention for infant siblings of children with autism if any concerns arise about their development, according to new research. The largest prospective investigation of autism spectrum disorder and sibling recurrence to date uncovered surprisingly high occurrence of autism, especially when more than 1 older sibling had the disorder.
Screening for autism in very premature babies more accurate at 30 monthsMay 13th 2011
A large number of positive screens for autism spectrum disorder (ASD) at 18 months in infants who were born very preterm actually may be because of cognitive and language delay, according to research presented at the 2011 Pediatric Academic Societies meeting in Denver.
Medicaid ADHD treatment needs to be betterJanuary 7th 2011
The care that children with attention-deficit/hyperactivity disorder (ADHD) receive under managed-care Medicaid programs has much room for improvement, a new study in the Journal of the American Academy of Child and Adolescent Psychiatry suggests.
Cardiovascular risk in ADHD pharmacotherapyNovember 1st 2009
Pharmacotherapy, namely the stimulant medications methylphenidate (MPH) and amphetamine (MAS) and the nonstimulant medication atomoxetine (Strattera), is the recommended treatment for attention-deficit/hyperactivity disorder (ADHD).
ADHD: Evaluating advances in treatmentNovember 1st 2009
An article published in Contemporary Pediatrics 25 years ago instructed pediatricians on medications to treat attention deficit disorders (ADD). Their observations were so perceptive that, with a few tweaks, they could be republished as a 2009 update on attention deficit/hyperactivity disorder (ADHD).